Biotest Aktiengesellschaft (FRA:BIO)

Germany · Delayed Price · Currency is EUR

101.26

+0.98 (0.98%)

Dec 3, 2017, 3:45 PM EST

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
European Union	264.60M	-	-
Rest of The World	251.50M	-	-
Therapy	-	461.60M	430.50M
Therapy Growth	-	7.22%	15.76%
Plasma & Services	-	46.70M	46.70M
Plasma & Services Growth	-	0%	18.23%
Other	-	7.30M	7.00M
Other Growth	-	4.29%	-9.09%
Total	516.10M	515.60M	484.20M
Total Growth	0.10%	6.48%	15.53%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Germany	684.80M	616.20M	393.20M	-	-
Germany Growth	11.13%	56.71%	-	-	-
Rest of World	41.40M	68.40M	122.80M	-	-
Rest of World Growth	-39.47%	-44.30%	-	-	-
Central Europe	-	-	-	186.90M	174.90M
Central Europe Growth	-	-	-	6.86%	0.81%
Eastern and Southern Europe, Central Asia, America*	-	-	-	138.10M	-
Other	-	-	-	75.90M	83.90M
Other Growth	-	-	-	-9.54%	1.57%
Middle East, Africa and France	-	-	-	114.70M	109.00M
Middle East, Africa and France Growth	-	-	-	5.23%	40.10%
East and South Europe	-	-	-	-	116.50M
East and South Europe Growth	-	-	-	-	36.74%
Total	726.20M	684.60M	516.00M	515.60M	484.30M
Total Growth	6.08%	32.67%	0.08%	6.46%	15.56%

Source: S&P Global Market Intelligence.